CONDUIT PHARMACEUTICALS INC.

Highlights Conduit Pharmaceuticals Inc.

Equities

CDT

US20678X1063

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-21 EDT			5-day change	1st Jan Change
1.56 ^USD	+6.85%		-13.33%	-65.71%

06-13	Conduit Pharmaceuticals Set to Join Russell 3000 Index Effective July 1	MT
05-14	Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Conduit Pharmaceuticals Set to Join Russell 3000 Index Effective July 1	06-13	MT
Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Conduit Pharmaceuticals Inc. Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub	03-11	CI
Top Premarket Gainers	23-10-25	MT
Conduit Pharmaceuticals, ClinConnect Enter Drug Development Collaboration	23-10-11	MT
ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656	23-10-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer